AI-powered contentSome parts of this article are powered by AI.
Share this article
Summary
UnitedHealth (UNH) closed at $395.62 on October 14, 2026, up 4.73% while the Nasdaq fell 1.88%.
Financial media tied the gain to third-quarter adjusted earnings of $4.69 per share and a full-year outlook raised to at least $20.50.
Shrinking membership and elevated commercial medical costs remain the main risks flagged by analysts.
Gotrade News - Shares of UnitedHealth (UNH) closed at $395.62 on Wednesday, October 14, 2026, up $17.86 or 4.73% in a session that sent the Nasdaq Composite down 1.88%. In today's unitedhealth stock news, financial media tied the gain to the insurer's third-quarter 2026 results, which beat estimates and came with a higher full-year profit outlook.
UNH Trading Data
Data
Value
Closing price
$395.62
Change
+$17.86 (+4.73%)
Previous close
$377.76
Open
$382.29
Day range
$382.29 to $396.44
Volume
7.8 million shares
30-day average volume
5.5 million shares
52-week range
$255.97 to $461.62
Market cap
$339.1 billion
Regular-session close on Wednesday, October 14, 2026, 4:00 p.m. New York time. Stock prices: Yahoo Finance, cross-checked against Nasdaq's official close. Indices, the 10-year Treasury yield and oil (Brent and WTI front-month futures): Yahoo Finance daily closes for the same date.
UNH opened at $382.29, which also proved to be the session low, and climbed steadily to finish $13.33 above that level, close to the day high of $396.44. Volume reached 7.8 million shares, 42.00% above the 5.5 million share average, a sign of heavier interest than usual.
The gain stood out against a weak tape. The S&P 500 fell 1.11% to 7,718.94 and the Dow Jones Industrial Average slipped 0.09% to 51,621.48, leaving UNH 6.61 percentage points ahead of the Nasdaq. Among large caps, Nvidia (NVDA) dropped 3.16%, while Costco (COST) was one of the few gainers at 2.87%. The US 10-year Treasury yield eased 2.7 basis points to 5.19%.
Even after the rally, the stock sits 14.30% below its 52-week high of $461.62 and 54.56% above its 52-week low of $255.97.
According to the company's third-quarter 2026 earnings release filed with the SEC on October 13, 2026, UnitedHealth Group earned $4.69 per share on an adjusted basis on revenue of $112.7 billion, and raised its full-year 2026 outlook to adjusted earnings of at least $20.50 per share.
The medical care ratio improved to 88.4% from 89.9% a year earlier, and CEO Stephen Hemsley said the results "reflect the discipline and execution our teams are bringing to every part of our business."
Per Zacks, the adjusted figure compared with a consensus estimate of $4.12, and CFO Wayne DeVeydt said the low end of the company's 13% to 16% long-term earnings growth target is a reasonable starting point for 2027. As reported by StockStory, the shares rose after the third-quarter results topped expectations and lifted the profit outlook.
The rally came one session late. According to 24/7 Wall St., the stock closed down 0.23% on earnings day after opening higher, as investors weighed the beat against shrinking membership.
UNH Stock Analysis: Supporting Factors and Risks
Supporting Factors
Optum Health's third-quarter operating earnings rose to $735 million from $41 million a year earlier, according to Zacks.
The operating cost ratio fell to 12.8% from 13.5%, and cash flow from operations reached $5.1 billion, per the SEC filing.
Management plans to give a fuller 2027 outlook before year-end, according to Zacks.
Risks
UnitedHealthcare served 48.3 million members, down from 50.1 million a year earlier, and Medicare Advantage has lost 935,000 members this year, per 24/7 Wall St.
24/7 Wall St. noted that $610 million of favorable prior-period reserve development helped the medical care ratio improve, a boost that may not repeat.
Commercial medical cost trends remain above the company's initial 11% expectation, driven by specialty drugs and clinician costs, according to Zacks.
Justice Department actions tied to its Medicare business and CMS Star Ratings remain open risks, per 24/7 Wall St.
This article is for education and information only and is not investment advice. Investment decisions are yours to make after your own research.
Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA). This content is for educational purposes only and does not constitute financial advice. Always do your own research (DYOR) before investing.
M. Alfathan Rahman is a content writer with over 3 years of experience developing digital content strategies across various industries, including fintech. He has experience producing content for tax-related websites and financial education platforms registered with Kominfo (Indonesia's Ministry of Communication and Informatics). His focus areas include data research, and crafting financial articles that are informative, accurate, and accessible to investors of all experience levels.
Hendrie Saputra holds a Master of Business Administration (MBA) with a concentration in Business Risk & Finance, along with professional experience in finance, marketing, and project management. He is experienced in analyzing market data and developing research-driven business strategies.
